Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 13

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda

Ahmed, Ishtiaq, Nijs, Jo, Vanroose, Matteo, Vandeputte, Doris, Kindt, Sébastien, Elma, Ömer, Hendrix, Jolien, Huysmans, Eva, Lahousse, Astrid · 2025 · International Journal of Molecular Sciences

Abstract

Given the limited efficacy of current interventions and the complexity of chronic pain, identifying perpetuating factors is crucial for uncovering new mechanistic pathways and treatment targets. The oral and gut microbiome has emerged as a potential modulator of pain through immune, metabolic, and neural mechanisms. Contemporary evidence indicates that chronic pain populations exhibit altered oral and gut microbiota, characterized by reduced short-chain fatty acid (SCFA)-producing taxa and an overrepresentation of pro-inflammatory species. These compositional changes affect metabolites such as SCFAs, bile acids, and microbial cell wall components, which interact with host receptors to promote peripheral and central sensitization. Microbiota-derived metabolites modulate peripheral sensitization by altering nociceptive neuron excitability and stimulating immune cells to release pro-inflammatory cytokines that increase blood–brain barrier permeability, activate microglia, and amplify neuroinflammation. Activated microglia further disrupt the balance between excitatory and inhibitory neurotransmission by enhancing glutamatergic activity and weakening GABAergic signaling, thereby contributing to the induction and maintenance of central sensitization. While observational studies establish associations between dysbiosis and chronic pain, animal models and early human fecal microbiota transplantation studies suggest a potential causal role of dysbiosis in pain, although human evidence remains preliminary and influenced by diet, lifestyle, and comorbidities. Overall, microbiota appears to regulate pain via peripheral and central mechanisms, and targeting it through specific interventions, such as dietary modulation to enhance SCFA production, alongside broader lifestyle measures like sleep, physical activity, stress management, and oral hygiene, may represent a new therapeutic strategy for the management of chronic pain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms27010114

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 242

  1. Ferreira, 2023, Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021, Lancet Rheumatol., 5, e316, 10.1016/S2665-9913(23)00098-X · DOI · Paper page
  2. Abd-Elsayed, A. (2020). Economic Burden of Pain. Guide to the Inpatient Pain Consult, Springer International Publishing. · doi:10.1007/978-3-030-40449-9
  3. Nijs, J., Malfliet, A., Roose, E., Lahousse, A., Van Bogaert, W., Johansson, E., Runge, N., Goossens, Z., Labie, C., and Bilterys, T. (2024). Personalized multimodal lifestyle intervention as the best-evidenced treatment for chronic pain: State-of-the-art clinical perspective. J. Clin. Med., 13. · DOI
  4. Eccleston, 2019, Pharmacological interventions for chronic pain in children: An overview of systematic reviews, Pain, 160, 1698, 10.1097/j.pain.0000000000001609 · DOI
  5. McDonagh, M.S., Selph, S.S., Buckley, D.I., Holmes, R.S., Mauer, K., Ramirez, S., Hsu, F.C., Dana, T., Fu, R., and Chou, R. (2020). Nonopioid Pharmacologic Treatments for Chronic Pain, American Academy of Family Physicians. · DOI
  6. Chou, 2017, Systemic pharmacologic therapies for low back pain: A systematic review for an American College of Physicians clinical practice guideline, Ann. Intern. Med., 166, 480, 10.7326/M16-2458 · DOI · Paper page
  7. Billens, 2022, Systemic Cytokine Level Differences in Patients with Chronic Musculoskeletal Spinal Pain Compared to Healthy Controls and Its Association with Pain Severity: A Systematic Review, Pain Med., 23, 1947, 10.1093/pm/pnac091 · DOI
  8. Nijs, 2021, Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine, Lancet Rheumatol., 3, e383, 10.1016/S2665-9913(21)00032-1 · DOI · Paper page
  9. Guo, 2019, Pain regulation by gut microbiota: Molecular mechanisms and therapeutic potential, Br. J. Anaesth., 123, 637, 10.1016/j.bja.2019.07.026 · DOI · Paper page
  10. Goudman, L., Demuyser, T., Pilitsis, J.G., Billot, M., Roulaud, M., Rigoard, P., and Moens, M. (2024). Gut dysbiosis in patients with chronic pain: A systematic review and meta-analysis. Front. Immunol., 15. · DOI
  11. Zhao, M., Zhang, L., and Liu, Z. (2025). Gut microbiota-mediated pain sensitization: Mechanisms and therapeutic implications. Front. Pain Res., 6. · DOI
  12. Adil, N.A., Omo-Erigbe, C., Yadav, H., and Jain, S. (2025). The oral–gut microbiome–brain axis in cognition. Microorganisms, 13. · DOI
  13. 2024, Implication of intestinal microbiota in the etiopathogenesis of fibromyalgia: A systematic review, Int. J. Rheum. Dis., 27, e15021, 10.1111/1756-185X.15021 · DOI
  14. Sejbuk, M., Siebieszuk, A., and Witkowska, A.M. (2024). The role of gut microbiome in sleep quality and health: Dietary strategies for microbiota support. Nutrients, 16. · DOI
  15. Olsen, 2019, Can oral bacteria affect the microbiome of the gut?, J. Oral Microbiol., 11, 1586422, 10.1080/20002297.2019.1586422 · DOI · Paper page
  16. Liu, S., Li, G., Zhu, Y., Xu, C., Yang, Q., Xiong, A., Weng, J., Yu, F., and Zeng, H. (2022). Analysis of gut microbiome composition, function, and phenotype in patients with osteoarthritis. Front. Microbiol., 13. · DOI
  17. Erdrich, S., Gelissen, I.C., Vuyisich, M., Toma, R., and Harnett, J.E. (2025). An association between poor oral health, oral microbiota, and pain identified in New Zealand women with central sensitisation disorders: A prospective clinical study. Front. Pain Res., 6. · DOI
  18. Costa, C.F., Correia-de-Sá, T., Araujo, R., Barbosa, F., Burnet, P.W., Ferreira-Gomes, J., and Sampaio-Maia, B. (2024). The oral-gut microbiota relationship in healthy humans: Identifying shared bacteria between environments and age groups. Front. Microbiol., 15. · DOI
  19. Blekhman, 2015, Host genetic variation impacts microbiome composition across human body sites, Genome Biol., 16, 191, 10.1186/s13059-015-0759-1 · DOI · Paper page
  20. Markle, 2013, Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity, Science, 339, 1084, 10.1126/science.1233521 · DOI · Paper page
  21. Rajasekaran, J.J., Krishnamurthy, H.K., Bosco, J., Jayaraman, V., Krishna, K., Wang, T., and Bei, K. (2024). Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. Microorganisms, 12. · doi:10.20944/preprints202406.1923.v1
  22. Govender, 2025, Population-specific differences in the human microbiome: Factors defining the diversity, Gene, 933, 148923, 10.1016/j.gene.2024.148923 · DOI
  23. Ho, T., Elma, Ö., Kocanda, L., Brain, K., Lam, T., Kanhere, T., and Dong, H.-J. (2025). The brain-gut axis and chronic pain: Mechanisms and therapeutic opportunities. Front. Neurosci., 19. · DOI
  24. Kennedy, 2014, Irritable bowel syndrome: A microbiome-gut-brain axis disorder?, World J. Gastroenterol. WJG, 20, 14105, 10.3748/wjg.v20.i39.14105 · DOI · Paper page
  25. Karlsson, 2013, Assessing the human gut microbiota in metabolic diseases, Diabetes, 62, 3341, 10.2337/db13-0844 · DOI · Paper page
  26. Abecia, 2019, Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia, eBioMedicine, 46, 499, 10.1016/j.ebiom.2019.07.031 · DOI · Paper page
  27. Manske, 2024, The Microbiome’s Role in Chronic Pain and Inflammation, Integr. Med., 23, 10
  28. Erdrich, 2025, Characterisation of the Oral Microbiome in Women With Fibromyalgia: An Observational Case–Control Study, Eur. J. Pain, 29, e70051, 10.1002/ejp.70051 · DOI
  29. Kroese, 2021, Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals, Arthritis Rheumatol., 73, 1986, 10.1002/art.41780 · DOI
  30. Ma, 2022, Fibromyalgia and periodontitis: Bidirectional associations in population-based 15-year retrospective cohorts, J. Periodontol., 93, 877, 10.1002/JPER.21-0256 · DOI
  31. Chen, X., Xue, D., Zhao, Y., Cui, P., Wang, P., Wang, Y., and Lu, S.B. (2023). Association between periodontitis and disc structural failure in older adults with lumbar degenerative disorders: A prospective cohort study. BMC Surg., 23. · DOI
  32. Dietrich, 2008, Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population, J. Rheumatol., 35, 70
  33. Liu, X.-f., Shao, J.-h., Liao, Y.-T., Wang, L.-N., Jia, Y., Dong, P.-j., Liu, Z.-z., He, D.-d., Li, C., and Zhang, X. (2023). Regulation of short-chain fatty acids in the immune system. Front. Immunol., 14. · DOI · Paper page
  34. Xu, 2025, The oral-gut microbiota axis: A link in cardiometabolic diseases, npj Biofilms Microbiomes, 11, 11, 10.1038/s41522-025-00646-5 · DOI
  35. Kitamoto, 2020, The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis, Cell, 182, 447, 10.1016/j.cell.2020.05.048 · DOI · Paper page
  36. Guo, 2024, Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa, Gut Microbes, 16, 2333463, 10.1080/19490976.2024.2333463 · DOI
  37. Li, 2024, Oral inoculation of Fusobacterium nucleatum exacerbates ulcerative colitis via the secretion of virulence adhesin FadA, Virulence, 15, 2399217, 10.1080/21505594.2024.2399217 · DOI
  38. Tsuzuno, 2021, Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice, J. Periodontal Res., 56, 275, 10.1111/jre.12816 · DOI
  39. Sohn, 2022, Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4(+) T cells, Mol. Oral Microbiol., 37, 42, 10.1111/omi.12359 · DOI
  40. Jie, Z., Ziyi, J., Yu, F., Gao, L., Wang, X., and Wang, Q. (2025). Integrated oral-gut microbiota therapy: A novel perspective on preventing bacterial translocation for systemic disease management. Front. Cell. Infect. Microbiol., 15. · DOI
  41. Leonov, G.E., Varaeva, Y.R., Livantsova, E.N., and Starodubova, A.V. (2023). The Complicated Relationship of Short-Chain Fatty Acids and Oral Microbiome: A Narrative Review. Biomedicines, 11. · DOI
  42. Ndeh, 2018, Biochemistry of complex glycan depolymerisation by the human gut microbiota, FEMS Microbiol. Rev., 42, 146, 10.1093/femsre/fuy002 · DOI · Paper page
  43. Santacroce, 2023, Oral microbiota in human health and disease: A perspective, Exp. Biol. Med., 248, 1288, 10.1177/15353702231187645 · DOI
  44. Magrin, G.L., Strauss, F.J., Benfatti, C.A.M., Maia, L.C., and Gruber, R. (2020). Effects of Short-Chain Fatty Acids on Human Oral Epithelial Cells and the Potential Impact on Periodontal Disease: A Systematic Review of In Vitro Studies. Int. J. Mol. Sci., 21. · DOI
  45. Zhang, 2023, The Commensal Anaerobe Veillonella dispar Reprograms Its Lactate Metabolism and Short-Chain Fatty Acid Production during the Stationary Phase, Microbiol. Spectr., 11, e0355822, 10.1128/spectrum.03558-22 · DOI
  46. Louis, 2017, Formation of propionate and butyrate by the human colonic microbiota, Environ. Microbiol., 19, 29, 10.1111/1462-2920.13589 · DOI · Paper page
  47. Koh, 2016, From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites, Cell, 165, 1332, 10.1016/j.cell.2016.05.041 · DOI · Paper page
  48. Wong, 2006, Colonic health: Fermentation and short chain fatty acids, J. Clin. Gastroenterol., 40, 235, 10.1097/00004836-200603000-00015 · DOI · Paper page
  49. Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., and Ruffolo, C. (2024). Short-chain fatty acids and human health: From metabolic pathways to current therapeutic implications. Life, 14. · DOI
  50. Hodgkinson, 2023, Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease, Clin. Nutr., 42, 61, 10.1016/j.clnu.2022.10.024 · DOI · Paper page
  51. Louis, 2014, The gut microbiota, bacterial metabolites and colorectal cancer, Nat. Rev. Microbiol., 12, 661, 10.1038/nrmicro3344 · DOI · Paper page
  52. Groen, 2013, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res., 54, 2325, 10.1194/jlr.R036012 · DOI · Paper page
  53. Nogal, 2021, The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health, Gut Microbes, 13, 1897212, 10.1080/19490976.2021.1897212 · DOI · Paper page
  54. Agus, 2018, Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host Microbe, 23, 716, 10.1016/j.chom.2018.05.003 · DOI · Paper page
  55. Rebeaud, J., Peter, B., and Pot, C. (2022). How microbiota-derived metabolites link the gut to the brain during neuroinflammation. Int. J. Mol. Sci., 23. · DOI
  56. Ridlon, 2006, Bile salt biotransformations by human intestinal bacteria, J. Lipid Res., 47, 241, 10.1194/jlr.R500013-JLR200 · DOI · Paper page
  57. Guzior, 2021, Microbial transformations of human bile acids, Microbiome, 9, 140, 10.1186/s40168-021-01101-1 · DOI · Paper page
  58. Raetz, 2002, Lipopolysaccharide endotoxins, Annu. Rev. Biochem., 71, 635, 10.1146/annurev.biochem.71.110601.135414 · DOI · Paper page
  59. Typas, 2011, From the regulation of peptidoglycan synthesis to bacterial growth and morphology, Nat. Rev. Microbiol., 10, 123, 10.1038/nrmicro2677 · DOI · Paper page
  60. Rahman, 2023, The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects, Curr. Rheumatol. Rep., 25, 307, 10.1007/s11926-023-01108-7 · DOI
  61. Vargas, 2025, Gut microbiota-derived metabolites and chronic inflammatory diseases, Explor. Med., 6, 1001275, 10.37349/emed.2025.1001275 · DOI
  62. Matsuda, 2024, Effect of periodontal treatment on reducing chronic inflammation in systemically healthy patients with periodontal disease, Am. J. Med., 137, 273, 10.1016/j.amjmed.2023.11.001 · DOI
  63. Brito, 2013, Experimental periodontitis promotes transient vascular inflammation and endothelial dysfunction, Arch. Oral Biol., 58, 1187, 10.1016/j.archoralbio.2013.03.009 · DOI
  64. Yue, Z., Fan, Y., Shan, G., and Chen, X. (2025). Oral microbiome contributions to metabolic syndrome pathogenesis. Front. Microbiol., 16. · DOI
  65. Carrouel, F., Viennot, S., Santamaria, J., Veber, P., and Bourgeois, D. (2016). Quantitative molecular detection of 19 major pathogens in the interdental biofilm of periodontally healthy young adults. Front. Microbiol., 7. · DOI
  66. Lamont, R.J., and Kuboniwa, M. (2024). The polymicrobial pathogenicity of Porphyromonas gingivalis. Front. Oral Health, 5. · DOI
  67. Groeger, S., Jarzina, F., Domann, E., and Meyle, J. (2017). Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells. BMC Immunol., 18. · DOI
  68. Park, S.Y., Hwang, B.O., Lim, M., Ok, S.H., Lee, S.K., Chun, K.S., Park, K.K., Hu, Y., Chung, W.Y., and Song, N.Y. (2021). Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers, 13. · DOI · Paper page
  69. Lu, J., Wang, Y., Wu, J., Duan, Y., Zhang, H., and Du, H. (2025). Linking microbial communities to rheumatoid arthritis: Focus on gut, oral microbiome and their extracellular vesicles. Front. Immunol., 16. · DOI
  70. Wu, H., Qiu, W., Zhu, X., Li, X., Xie, Z., Carreras, I., Dedeoglu, A., Van Dyke, T., Han, Y.W., and Karimbux, N. (2022). The periodontal pathogen fusobacterium nucleatum exacerbates Alzheimer’s pathogenesis via specific pathways. Front. Aging Neurosci., 14. · DOI
  71. Oue, 2024, Oral administration of Porphyromonas gingivalis to mice with diet-induced obesity impairs cognitive function associated with microglial activation in the brain, J. Oral Microbiol., 16, 2419155, 10.1080/20002297.2024.2419155 · DOI
  72. Olsen, 2016, Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases, J. Oral Microbiol., 8, 30385, 10.3402/jom.v8.30385 · DOI
  73. Hu, 2021, Activated STAT3 signaling pathway by ligature-induced periodontitis could contribute to neuroinflammation and cognitive impairment in rats, J. Neuroinflamm, 18, 80, 10.1186/s12974-021-02071-9 · DOI
  74. Nagashima, 2017, CXCR4 signaling in macrophages contributes to periodontal mechanical hypersensitivity in Porphyromonas gingivalis-induced periodontitis in mice, Mol. Pain, 13, 1744806916689269, 10.1177/1744806916689269 · doi:10.1177/1744806916689269
  75. Kaewpitak, 2020, Porphyromonas gingivalis lipopolysaccharide rapidly activates trigeminal sensory neurons and may contribute to pulpal pain, Int. Endod. J., 53, 846, 10.1111/iej.13282 · DOI
  76. Shimizu, K., Matsumoto, K., Noma, N., Matsuura, S., Ohara, K., Komiya, H., Watase, T., Ogiso, B., Tsuboi, Y., and Shinoda, M. (2014). Involvement of trigeminal transition zone and laminated subnucleus caudalis in masseter muscle hypersensitivity associated with tooth inflammation. PLoS ONE, 9. · DOI
  77. Worsley, 2014, Chronic tooth pulp inflammation induces persistent expression of phosphorylated ERK (pERK) and phosphorylated p38 (pp38) in trigeminal subnucleus caudalis, Neuroscience, 269, 318, 10.1016/j.neuroscience.2014.03.056 · doi:10.1016/j.neuroscience.2014.03.056
  78. Yamazaki, 2024, Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases, Mucosal Immunol., 17, 147, 10.1016/j.mucimm.2023.11.006 · DOI
  79. Yamazaki, 2023, Oral-gut axis as a novel biological mechanism linking periodontal disease and systemic diseases: A review, Jpn. Dent. Sci. Rev., 59, 273, 10.1016/j.jdsr.2023.08.003 · DOI
  80. Peng, 2022, Oral microbiota in human systematic diseases, Int. J. Oral Sci., 14, 14, 10.1038/s41368-022-00163-7 · DOI · Paper page
  81. Nakajima, M., Arimatsu, K., Kato, T., Matsuda, Y., Minagawa, T., Takahashi, N., Ohno, H., and Yamazaki, K. (2015). Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS ONE, 10. · DOI · Paper page
  82. Bao, 2022, Periodontitis may induce gut microbiota dysbiosis via salivary microbiota, Int. J. Oral Sci., 14, 32, 10.1038/s41368-022-00183-3 · DOI · Paper page
  83. Gu, X., Song, L.J., Li, L.X., Liu, T., Zhang, M.M., Li, Z., Wang, P., Li, M., and Zuo, X.L. (2020). Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner. Front. Microbiol., 11. · DOI
  84. Verri, 2017, Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation, Trends Immunol., 38, 5, 10.1016/j.it.2016.10.001 · DOI · Paper page
  85. Li, Y., Zhu, M., Liu, Y., Luo, B., Cui, J., Huang, L., Chen, K., and Liu, Y. (2022). The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights. Front. Immunol., 13. · DOI
  86. Fleetwood, A.J., Lee, M.K., Singleton, W., Achuthan, A., Lee, M.-C., O’Brien-Simpson, N.M., Cook, A.D., Murphy, A.J., Dashper, S.G., and Reynolds, E.C. (2017). Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Front. Cell. Infect. Microbiol., 7. · DOI · Paper page
  87. Haraga, 2022, Effect of the Progression of Fusobacterium nucleatum–induced Apical Periodontitis on the Gut Microbiota, J. Endod., 48, 1038, 10.1016/j.joen.2022.04.014 · DOI
  88. Baker, 2024, The oral microbiome: Diversity, biogeography and human health, Nat. Rev. Microbiol., 22, 89, 10.1038/s41579-023-00963-6 · DOI · Paper page
  89. Tortora, S.C., Agurto, M.G., and Martello, L.A. (2023). The oral-gut-circulatory axis: From homeostasis to colon cancer. Front. Cell. Infect. Microbiol., 13. · DOI
  90. Pihlstrom, 2005, Periodontal diseases, Lancet, 366, 1809, 10.1016/S0140-6736(05)67728-8 · DOI · Paper page
  91. Weinstock, 2012, Genomic approaches to studying the human microbiota, Nature, 489, 250, 10.1038/nature11553 · DOI · Paper page
  92. Luczynski, 2017, Microbiota regulates visceral pain in the mouse, eLife, 6, e25887, 10.7554/eLife.25887 · DOI · Paper page
  93. Vieira, 2015, A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout, Arthritis Rheumatol., 67, 1646, 10.1002/art.39107 · DOI · Paper page
  94. Lee, 2023, Nerve injury-induced gut dysbiosis contributes to spinal cord TNF-α expression and nociceptive sensitization, Brain Behav. Immun., 110, 155, 10.1016/j.bbi.2023.03.005 · DOI
  95. Cai, 2025, The gut microbiota promotes pain in fibromyalgia, Neuron, 113, 2161, 10.1016/j.neuron.2025.03.032 · DOI · Paper page
  96. Powley, 2008, Ultrastructural evidence for communication between intramuscular vagal mechanoreceptors and interstitial cells of Cajal in the rat fundus, Neurogastroenterol. Motil., 20, 69, 10.1111/j.1365-2982.2007.00990.x · DOI
  97. Morris, 2020, The role of the locus coeruleus in the generation of pathological anxiety, Brain Neurosci. Adv., 4, 2398212820930321, 10.1177/2398212820930321 · DOI · Paper page
  98. Ma, 2009, Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli, Am. J. Physiol.-Gastrointest. Liver Physiol., 296, G868, 10.1152/ajpgi.90511.2008 · DOI
  99. Wang, 2013, Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents, Am. J. Physiol.-Gastrointest. Liver Physiol., 304, G211, 10.1152/ajpgi.00128.2012 · DOI · Paper page
  100. Jameson, 2025, Select microbial metabolites in the small intestinal lumen regulates vagal activity via receptor-mediated signaling, iScience, 28, 111699, 10.1016/j.isci.2024.111699 · DOI
  101. Siopi, 2023, Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice, Mol. Psychiatry, 28, 3002, 10.1038/s41380-023-02071-6 · DOI · Paper page
  102. Woda, 2016, Dysfunctional stress responses in chronic pain, Psychoneuroendocrinology, 71, 127, 10.1016/j.psyneuen.2016.05.017 · DOI
  103. Tosato, 2015, Correlation of stress and muscle activity of patients with different degrees of temporomandibular disorder, J. Phys. Ther. Sci., 27, 1227, 10.1589/jpts.27.1227 · DOI
  104. Kim, 2012, Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome, Oral Dis., 18, 613, 10.1111/j.1601-0825.2012.01937.x · DOI
  105. Nijhof, 2014, The role of hypocortisolism in chronic fatigue syndrome, Psychoneuroendocrinology, 42, 199, 10.1016/j.psyneuen.2014.01.017 · DOI
  106. Chang, 2009, Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome, Neurogastroenterol. Motil., 21, 149, 10.1111/j.1365-2982.2008.01171.x · DOI · Paper page
  107. Coppens, 2018, Cortisol and Subjective Stress Responses to Acute Psychosocial Stress in Fibromyalgia Patients and Control Participants, Psychosom. Med., 80, 317, 10.1097/PSY.0000000000000551 · DOI
  108. Bowie, 1998, Activity-dependent modulation of glutamate receptors by polyamines, J. Neurosci., 18, 8175, 10.1523/JNEUROSCI.18-20-08175.1998 · DOI
  109. Kim, 2023, Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity, Cell. Mol. Immunol., 20, 341, 10.1038/s41423-023-00987-1 · DOI · Paper page
  110. Li, 2018, Pro-and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells, Eur. J. Pharmacol., 831, 52, 10.1016/j.ejphar.2018.05.003 · DOI · Paper page
  111. Takeda, M., Sashide, Y., and Utugi, S. (2025). Neurophysiological Basis of Short-Chain Fatty Acid Action in Pain Modulation: Therapeutic Implications. Int. J. Mol. Sci., 26. · DOI
  112. Sashide, Y., Utugi, S., and Takeda, M. (2025). A Short-Chain Fatty Acid, Butyrate, Suppresses the Hyperexcitability of Rat Nociceptive Primary Neurons Involved in Inflammatory Hyperalgesia. Molecules, 30. · DOI
  113. Takeda, 2009, Contribution of the activation of satellite glia in sensory ganglia to pathological pain, Neurosci. Biobehav. Rev., 33, 784, 10.1016/j.neubiorev.2008.12.005 · DOI · Paper page
  114. Ruhnke, 2024, Expression of free fatty acid receptor 2 in normal and neoplastic tissues, Exp. Mol. Pathol., 137, 104902, 10.1016/j.yexmp.2024.104902 · doi:10.1016/j.yexmp.2024.104902
  115. Taing, 2023, Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain, Neural Regen. Res., 18, 763, 10.4103/1673-5374.354514 · DOI
  116. Vallabhapurapu, 2009, Regulation and function of NF-κB transcription factors in the immune system, Annu. Rev. Immunol., 27, 693, 10.1146/annurev.immunol.021908.132641 · DOI · Paper page
  117. Huang, 2020, Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling, Oxid. Med. Cell. Longev., 2020, 4074832, 10.1155/2020/4074832 · DOI · Paper page
  118. Lee, 2013, β-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-κB, Biol. Pharm. Bull., 36, 1754, 10.1248/bpb.b13-00312 · DOI
  119. Chen, 2001, Duration of nuclear NF-κB action regulated by reversible acetylation, Science, 293, 1653, 10.1126/science.1062374 · DOI · Paper page
  120. Ni, 2010, Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice, Respir. Res., 11, 33, 10.1186/1465-9921-11-33 · DOI
  121. Place, 2005, HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα, Biochem. Pharmacol., 70, 394, 10.1016/j.bcp.2005.04.030 · DOI · Paper page
  122. Segain, 2000, Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn’s disease, Gut, 47, 397, 10.1136/gut.47.3.397 · DOI · Paper page
  123. Liu, 2007, MAPK phosphatases—Regulating the immune response, Nat. Rev. Immunol., 7, 202, 10.1038/nri2035 · DOI · Paper page
  124. Noureldein, 2018, Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction, Microb. Pathog., 118, 98, 10.1016/j.micpath.2018.03.021 · DOI
  125. Tycko, 2020, High-throughput discovery and characterization of human transcriptional effectors, Cell, 183, 2020, 10.1016/j.cell.2020.11.024 · DOI · Paper page
  126. Nijs, 2020, Nutritional intervention in chronic pain: An innovative way of targeting central nervous system sensitization?, Expert Opin. Ther. Targets, 24, 793, 10.1080/14728222.2020.1784142 · DOI
  127. Mortensen, 2020, Exploring the intersection between genetic risk scores and coronary artery calcium–Mutually exclusive or complementary?, J. Cardiovasc. Comput. Tomogr., 14, 206, 10.1016/j.jcct.2019.05.014 · DOI
  128. Irwin, 2022, Quantifying and categorising national extinction-risk footprints, Sci. Rep., 12, 5861, 10.1038/s41598-022-09827-0 · DOI
  129. Grabowska, 2024, Effect of proinflammatory cytokines on blood-brain barrier integrity, Eur. Cytokine Netw., 35, 38, 10.1684/ecn.2024.0498 · DOI
  130. Zhen, 2021, Greater strength of selection and higher proportion of beneficial amino acid changing mutations in humans compared with mice and Drosophila melanogaster, Genome Res., 31, 110, 10.1101/gr.256636.119 · DOI
  131. Gao, 2010, Chemokines, neuronal–glial interactions, and central processing of neuropathic pain, Pharmacol. Ther., 126, 56, 10.1016/j.pharmthera.2010.01.002 · DOI · Paper page
  132. Gao, 2010, Targeting astrocyte signaling for chronic pain, Neurotherapeutics, 7, 482, 10.1016/j.nurt.2010.05.016 · DOI · Paper page
  133. Tieppo, 2024, Analysis of intestinal bacterial microbiota in individuals with and without chronic low back pain, Curr. Issues Mol. Biol., 46, 7339, 10.3390/cimb46070435 · DOI
  134. Freidin, 2021, An association between chronic widespread pain and the gut microbiome, Rheumatology, 60, 3727, 10.1093/rheumatology/keaa847 · DOI
  135. Mugo, 2025, Unravelling the gut-brain connection: A systematic review of migraine and the gut microbiome, J. Headache Pain, 26, 125, 10.1186/s10194-025-02039-7 · DOI
  136. Bonato, 2022, A systematic review of microbiome composition in osteoarthritis subjects, Osteoarthr. Cartil., 30, 786, 10.1016/j.joca.2021.12.006 · DOI
  137. Zhu, 2018, Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis, Mol. Med. Rep., 17, 7567
  138. Luo, 2019, Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response, Mol. Med. Rep., 20, 1007
  139. Hiippala, K., Barreto, G., Burrello, C., Diaz-Basabe, A., Suutarinen, M., Kainulainen, V., Bowers, J.R., Lemmer, D., Engelthaler, D.M., and Eklund, K.K. (2020). Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro. Front. Microbiol., 11. · DOI · Paper page
  140. Xing, 2021, Microbiota regulate innate immune signaling and protective immunity against cancer, Cell Host Microbe, 29, 959, 10.1016/j.chom.2021.03.016 · DOI
  141. Moore, 1976, Emendation of Bacteroidaceae and Butyrivibrio and descriptions of Desulfomonas gen. nov. and ten new species in the genera Desulfomonas, Butyrivibrio, Eubacterium, Clostridium, and Ruminococcus, Int. J. Syst. Evol. Microbiol., 26, 238
  142. Nguyen, 2020, Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate, Microbiome, 8, 118, 10.1186/s40168-020-00887-w · DOI · Paper page
  143. Liu, 2021, Blautia-a new functional genus with potential probiotic properties?, Gut Microbes, 13, 1875796, 10.1080/19490976.2021.1875796 · DOI · Paper page
  144. Wang, 2023, Ginsenoside Rg3 enriches SCFA-producing commensal bacteria to confer protection against enteric viral infection via the cGAS-STING-type I IFN axis, ISME J., 17, 2426, 10.1038/s41396-023-01541-7 · DOI
  145. Zheng, 2024, Noninvasive, microbiome-based diagnosis of inflammatory bowel disease, Nat. Med., 30, 3555, 10.1038/s41591-024-03280-4 · DOI
  146. Liu, 2020, Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation, J. Transl. Med., 18, 382, 10.1186/s12967-020-02539-x · DOI
  147. Li, 2021, Microbiome-encoded bile acid metabolism modulates colonic transit times, iScience, 24, 102508, 10.1016/j.isci.2021.102508 · DOI
  148. Li, X., Yao, Z., Qian, J., Li, H., and Li, H. (2024). Lactate Protects Intestinal Epithelial Barrier Function from Dextran Sulfate Sodium-Induced Damage by GPR81 Signaling. Nutrients, 16. · DOI
  149. Baker, 2024, Protease-induced excitation of dorsal root ganglion neurons in response to acute perturbation of the gut microbiota is associated with visceral and somatic hypersensitivity, Cell. Mol. Gastroenterol. Hepatol., 18, 101334, 10.1016/j.jcmgh.2024.03.006 · DOI
  150. Balakrishnan, 2023, Eggerthella lenta augments preclinical autoantibody production and metabolic shift mimicking senescence in arthritis, Sci. Adv., 9, eadg1129, 10.1126/sciadv.adg1129 · DOI
  151. Taneja, 2018, AB0137 Arthritis-associated eggerthella lenta modulate disease via metabolic and microbial alterations, Ann. Rheum. Dis., 77, 1260, 10.1136/annrheumdis-2018-eular.3179 · doi:10.1136/annrheumdis-2018-eular.3179
  152. Liu, 2024, Tryptophan metabolites and gut microbiota play an important role in pediatric migraine diagnosis, J. Headache Pain, 25, 2, 10.1186/s10194-023-01708-9 · DOI
  153. Papetti, 2024, Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation, J. Headache Pain, 25, 171, 10.1186/s10194-024-01871-7 · DOI
  154. Lanza, M., Filippone, A., Casili, G., Giuffrè, L., Scuderi, S.A., Paterniti, I., Campolo, M., Cuzzocrea, S., and Esposito, E. (2022). Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine. Int. J. Mol. Sci., 23. · DOI
  155. Wang, D., Liu, X., Shi, S., Ren, T., and Wang, W. (2024). Gut microbiota and metabolite variations in a migraine mouse model. Front. Cell. Infect. Microbiol., 13. · DOI
  156. Saija, C., Bertuccio, M.P., Scoglio, A., Macaione, V., Cacciola, F., Micalizzi, G., Caccamo, D., Muscoli, C., and Currò, M. (2025). Role of Vitamin D Status and Alterations in Gut Microbiota Metabolism in Fibromyalgia-Associated Chronic Inflammatory Pain. Biomedicines, 13. · DOI
  157. Cheng, 2025, Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome, Sci. Rep., 15, 43681, 10.1038/s41598-025-27564-y · DOI
  158. Guo, 2023, Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS, Cell Host Microbe, 31, 288, 10.1016/j.chom.2023.01.004 · DOI · Paper page
  159. Ceccarelli, 2018, Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients, Clin. Exp. Immunol., 194, 244, 10.1111/cei.13184 · DOI
  160. Li, Y., Guo, R., Oduro, P.K., Sun, T., Chen, H., Yi, Y., Zeng, W., Wang, Q., Leng, L., and Yang, L. (2022). The Relationship Between Porphyromonas Gingivalis and Rheumatoid Arthritis: A Meta-Analysis. Front. Cell. Infect. Microbiol., 12. · doi:10.3389/fcimb.2022.956417
  161. Fteita, 2022, Prevotella species as oral residents and infectious agents with potential impact on systemic conditions, J. Oral Microbiol., 14, 2079814, 10.1080/20002297.2022.2079814 · DOI · Paper page
  162. Shibata, 1997, Mycoplasma salivarium induces interleukin-6 and interleukin-8 in human gingival fibroblasts, FEMS Immunol. Med. Microbiol., 19, 275, 10.1111/j.1574-695X.1997.tb01097.x · DOI
  163. Picchianti-Diamanti, A., Panebianco, C., Salemi, S., Sorgi, M.L., Di Rosa, R., Tropea, A., Sgrulletti, M., Salerno, G., Terracciano, F., and D’Amelio, R. (2018). Analysis of gut microbiota in rheumatoid arthritis patients: Disease-related dysbiosis and modifications induced by etanercept. Int. J. Mol. Sci., 19. · DOI · Paper page
  164. Zhang, 2021, Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture, Med, 2, 74, 10.1016/j.medj.2020.07.001 · DOI
  165. Chang, 2014, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proc. Natl. Acad. Sci. USA, 111, 2247, 10.1073/pnas.1322269111 · DOI · Paper page
  166. Inan, 2000, The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line, Gastroenterology, 118, 724, 10.1016/S0016-5085(00)70142-9 · DOI · Paper page
  167. Qiu, 2013, Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis, J. Crohn’s Colitis, 7, e558, 10.1016/j.crohns.2013.04.002 · DOI · Paper page
  168. Osterreicher, 2000, Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition of IL-12 and up-regulation of IL-10 production, FASEB J., 14, 2380, 10.1096/fj.00-0359fje · DOI · Paper page
  169. Sokol, 2008, Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proc. Natl. Acad. Sci. USA, 105, 16731, 10.1073/pnas.0804812105 · DOI · Paper page
  170. Peng, 2009, Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, J. Nutr., 139, 1619, 10.3945/jn.109.104638 · DOI · Paper page
  171. Clooney, 2018, Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn’s disease and ulcerative colitis, J. Crohn’s Colitis, 12, 204, 10.1093/ecco-jcc/jjx137 · DOI
  172. Benus, 2010, Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects, Br. J. Nutr., 104, 693, 10.1017/S0007114510001030 · DOI · Paper page
  173. Duncan, 2002, Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine, Appl. Environ. Microbiol., 68, 5186, 10.1128/AEM.68.10.5186-5190.2002 · DOI · Paper page
  174. Song, 2022, Roseburia hominis Alleviates Neuroinflammation via Short-Chain Fatty Acids through Histone Deacetylase Inhibition, Mol. Nutr. Food Res., 66, e2200164, 10.1002/mnfr.202200164 · DOI · Paper page
  175. Singh, 2014, Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, Immunity, 40, 128, 10.1016/j.immuni.2013.12.007 · DOI · Paper page
  176. Pan, 2024, Roseburia intestinalis: A possible target for vascular calcification, Heliyon, 10, e39865, 10.1016/j.heliyon.2024.e39865 · DOI
  177. Jiang, 2025, Roseburia intestinalis-derived butyrate alleviates neuropathic pain, Cell Host Microbe, 33, 104, 10.1016/j.chom.2024.11.013 · DOI
  178. Notting, 2023, The butyrate-producing and spore-forming bacterial genus Coprococcus as a potential biomarker for neurological disorders, Gut Microbiome, 4, e16, 10.1017/gmb.2023.14 · DOI
  179. Altemani, 2021, Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota, Pregnancy Hypertens., 23, 211, 10.1016/j.preghy.2021.01.002 · DOI
  180. Holdeman, 1974, New genus, Coprococcus, twelve new species, and emended descriptions of four previously described species of bacteria from human feces, Int. J. Syst. Evol. Microbiol., 24, 260
  181. Nogal, A., Louca, P., Zhang, X., Wells, P.M., Steves, C.J., Spector, T.D., Falchi, M., Valdes, A.M., and Menni, C. (2021). Circulating levels of the short-chain fatty acid acetate mediate the effect of the gut microbiome on visceral fat. Front. Microbiol., 12. · DOI · Paper page
  182. Falony, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat. Microbiol., 4, 623, 10.1038/s41564-018-0337-x · DOI · Paper page
  183. Xu, 2024, Coprococcus eutactus screened from healthy adolescent attenuates chronic restraint stress-induced depression-like changes in adolescent mice: Potential roles in the microbiome and neurotransmitter modulation, J. Affect. Disord., 356, 737, 10.1016/j.jad.2024.04.050 · DOI
  184. Wang, Z., Jiang, D., Zhang, M., Teng, Y., and Huang, Y. (2023). Causal association between gut microbiota and fibromyalgia: A Mendelian randomization study. Front. Microbiol., 14. · DOI
  185. Osawa, 2023, Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients, J. Clin. Biochem. Nutr., 73, 77, 10.3164/jcbn.22-86 · DOI
  186. Gronow, 2011, Complete genome sequence of Odoribacter splanchnicus type strain (1651/6), Stand. Genomic Sci., 4, 200, 10.4056/sigs.1714269 · DOI
  187. Hajra, D., Mukherjee, D., Vij, R., Rajmani, R.S., Dadireddy, V., Das, D., Hussain, T., Ganji, M., Tatu, U., and Chakravortty, D. (2024). Odoribacter splanchnicus mitigates pathogen-induced gut inflammation and its associated pathogenesis via its secreted bacteriocin. bioRxiv. · DOI
  188. Si, 2025, Lactobacillus rhamnosus GG induces STING-dependent IL-10 in intestinal monocytes and alleviates inflammatory colitis in mice, J. Clin. Investig., 135, e174910, 10.1172/JCI174910 · DOI
  189. Khare, 2020, Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice, Sci. Rep., 10, 18597, 10.1038/s41598-020-75702-5 · DOI
  190. Klemenak, 2015, Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease, Dig. Dis. Sci., 60, 3386, 10.1007/s10620-015-3769-7 · DOI
  191. Cai, Y., Wen, S., Hu, J., Wang, Z., Huang, G., Zeng, Q., and Zou, J. (2024). Multiple reports on the causal relationship between various chronic pain and gut microbiota: A two-sample Mendelian randomization study. Front. Neurosci., 18. · DOI
  192. Bai, 2018, Fecal microbiota transplantation is effective in relieving visceral hypersensitivity in a postinfectious model, BioMed Res. Int., 2018, 3860743, 10.1155/2018/3860743 · DOI
  193. Shabani, 2023, Evaluating the Effects of Probiotic Supplementation on Neuropathic Pain and Oxidative Stress Factors in an Animal Model of Chronic Constriction Injury of the Sciatic Nerve, Basic. Clin. Neurosci., 14, 375, 10.32598/bcn.2022.3772.1 · DOI
  194. Wang, 2024, Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: A retrospective review, Eur. J. Med. Res., 29, 148, 10.1186/s40001-024-01747-1 · DOI
  195. Gardiner, 2015, Clinical and microbiological characteristics of Eggerthella lenta bacteremia, J. Clin. Microbiol., 53, 626, 10.1128/JCM.02926-14 · DOI
  196. Alexander, 2022, Human gut bacterial metabolism drives Th17 activation and colitis, Cell Host Microbe, 30, 17, 10.1016/j.chom.2021.11.001 · DOI · Paper page
  197. Maeshima, N., and Fernandez, R.C. (2013). Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front. Cell. Infect. Microbiol., 3. · DOI · Paper page
  198. Pither, 2020, Pairing Bacteroides vulgatus LPS structure with its immunomodulatory effects on human cellular models, ACS Cent. Sci., 6, 1602, 10.1021/acscentsci.0c00791 · DOI
  199. Uemura, Y., Hiroshima, Y., Tada, A., Murakami, K., Yoshida, K., Inagaki, Y., Kuwahara, T., Murakami, A., Fujii, H., and Yumoto, H. (2022). Porphyromonas gingivalis Outer Membrane Vesicles Stimulate Gingival Epithelial Cells to Induce Pro-Inflammatory Cytokines via the MAPK and STING Pathways. Biomedicines, 10. · DOI
  200. Ciaston, 2022, Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis, mBio, 13, e0378721, 10.1128/mbio.03787-21 · DOI

200 of 242 shown

Metadata

Authors
Ahmed, I., Nijs, J., Vanroose, M., Vandeputte, D., Kindt, S., Elma, Ö., Hendrix, J., Huysmans, E., & Lahousse, A.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2025-12-22
Volume
27
Issue
1
Pages
114
ISSN
1422-0067
Cited by
13
References
45
Language
en
Funders
  • Strategic Research Program SRP90
  • Network for Social Impact of Science NSIS
  • research council of the Vrije Universiteit Brussel, Brussels, Belgium
  • cross-European Weave program 50
  • Research Foundation Flanders (G0894322N)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda. https://app.cochat.ai/papers/10.3390/ijms27010114
The paper
Ahmed, I., Nijs, J., Vanroose, M., Vandeputte, D., Kindt, S., Elma, Ö., Hendrix, J., Huysmans, E., & Lahousse, A. (2025). Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010114

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.